FR2081434B1 - - Google Patents

Info

Publication number
FR2081434B1
FR2081434B1 FR7100146A FR7100146A FR2081434B1 FR 2081434 B1 FR2081434 B1 FR 2081434B1 FR 7100146 A FR7100146 A FR 7100146A FR 7100146 A FR7100146 A FR 7100146A FR 2081434 B1 FR2081434 B1 FR 2081434B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7100146A
Other languages
French (fr)
Other versions
FR2081434A1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2081434A1 publication Critical patent/FR2081434A1/fr
Application granted granted Critical
Publication of FR2081434B1 publication Critical patent/FR2081434B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7100146A 1970-01-15 1971-01-05 Expired FR2081434B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702001604 DE2001604C2 (de) 1970-01-15 1970-01-15 Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung

Publications (2)

Publication Number Publication Date
FR2081434A1 FR2081434A1 (de) 1971-12-03
FR2081434B1 true FR2081434B1 (de) 1974-08-30

Family

ID=5759662

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7100146A Expired FR2081434B1 (de) 1970-01-15 1971-01-05

Country Status (4)

Country Link
JP (1) JPS4935410B1 (de)
DE (1) DE2001604C2 (de)
FR (1) FR2081434B1 (de)
GB (1) GB1286351A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US6110905A (en) * 1994-07-09 2000-08-29 Norbrook Laboratories Limited Long-acting oxytetracycline composition
GB9413873D0 (en) * 1994-07-09 1994-08-31 Norbrook Lab Ltd Long-acting oxytetracycline composition
WO2006130599A2 (en) 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions and methods for treating a damaged cardiovascular element
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US20080039433A1 (en) * 2006-06-15 2008-02-14 Smith Alexander D Stabilized Tetracycline Compositions
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
JP5763617B2 (ja) 2009-03-26 2015-08-12 ウォーソー・オーソペディック・インコーポレーテッド 標的化薬物送達用組成物のための潜在的成分を特定する方法
US9244060B2 (en) 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Also Published As

Publication number Publication date
DE2001604A1 (de) 1971-08-19
FR2081434A1 (de) 1971-12-03
DE2001604C2 (de) 1983-04-14
GB1286351A (en) 1972-08-23
JPS4935410B1 (de) 1974-09-21

Similar Documents

Publication Publication Date Title
AU1146470A (de)
AU1473870A (de)
AU2044470A (de)
AU2130570A (de)
AU1326870A (de)
AU1336970A (de)
AU1517670A (de)
AU1716970A (de)
AU1833270A (de)
AU2017870A (de)
AU2085370A (de)
AU1969370A (de)
AU1328670A (de)
AU2131570A (de)
AU2130770A (de)
AU1189670A (de)
AU2119370A (de)
AU2115870A (de)
AU2112570A (de)
AU1235770A (de)
AU2061170A (de)
AU2144270A (de)
AU1247570A (de)
AU1974970A (de)
AU1581370A (de)